Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive standard dataset of 16 ...

February 17, 2025 - DALLAS The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally ...

Long-time volunteer at Northwestern Medicine Delnor Hospital in Geneva celebrates procedure that saved her heart as hospital ...

The data are observational but intuitive, say experts. Further work might define where T-TEER’s greatest benefit lies.

Q4 2024 Earnings Call Transcript February 11, 2025 Edwards Lifesciences Corporation beats earnings expectations. Reported EPS ...

Overall, Edwards enjoys a great deal of financial flexibility that would allow for more substantial acquisitions, if those opportunities were to arise. Edwards Lifesciences has come to dominate ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy ...